Lutnick Brandon

Director Brandon Lutnick purchases 100,000 shares of CFTR-PRA in substantial open-market transaction.

Director Brandon Lutnick executed a material open-market purchase of 100,000 shares, representing a significant capital commitment to Cantor Fitzgerald Income Trust. Lutnick's track record shows nine consecutive prior purchases with no sales, establishing a pattern of sustained confidence in the company. However, this conviction is being tested against deteriorating fundamentals—the company is not currently profitable, with operating losses in both the most recent quarter and full-year results, and revenue growth is modest. The director's willingness to deploy substantial capital despite near-term financial headwinds suggests he views current valuations as attractive and sees recovery potential ahead, but the absence of profitability makes this a contrarian bet rather than a straightforward vote of confidence in a strong business.

Brandon Lutnick (Director) purchases 109,833,809 shares (109.83M) for $82,631,817.71 across 4 transactions on 2025-10-06; cluster buy with 2 other insiders in past 14 days

Director Brandon Lutnick acquired 109.83M shares across 4 separate transactions on 2025-10-06, with blended average price of $0.75, resulting in total investment of $82.6M. Three transactions were at $0.00 (totaling 101.5M shares), while one substantial purchase of 8,973,721 shares executed at $9.21 per share. The transaction occurred as BGC trades near the lower end of its 52-week range at $8.99, down 21.8% from the 52-week high and down 9.6% over 30 days. Notably, this acquisition follows a cluster pattern: 2 other insiders also purchased within the past 14 days. The company generated $784.0M in latest quarterly revenue with $57.5M net income and 11.7% annual revenue growth, maintaining a P/E of 34.58. Post-transaction holdings of 1.98M shares represent a significant long position despite the reversal from a short position of -107.86M shares pre-transaction.

Lutnick (CEO) purchases 300,000 shares of Cantor Equity Partners at undisclosed price; stock at $24.61, down 50.8% from 52-week high

Brandon Lutnick, Chairman and CEO, acquired 300,000 shares in Cantor Equity Partners on October 6, 2025, bringing his total holdings from zero to 300,000 shares. The purchase occurs at a significant discount to the 52-week high ($50.00), with the stock currently trading at $24.61, representing a 50.8% decline from its peak. This represents Lutnick's initial investment in the company and his first recorded open-market transaction in CEP, though he maintains a track record of 8 prior buys across other securities. The timing of this acquisition—following a substantial drawdown in share price but during a 21.2% gain over the preceding 30 days—suggests entry into a depressed valuation, though the transaction price itself is not disclosed in the filing.

CEO Lutnick buys 500,000 shares of CEPO at $0.00 valuation on 2025-10-06

Brandon Lutnick, Chairman and CEO, purchased 500,000 shares of Cantor Equity Partners I, Inc. (CEPO) at no apparent monetary cost on 2025-10-06, increasing his holdings from zero to 500,000 shares. The transaction's zero-dollar valuation suggests this was a non-cash acquisition—potentially a grant, equity award, or transfer rather than an open-market purchase. The stock is currently trading at $10.54, down 30.8% from its 52-week high of $15.24, and the company was unprofitable over its most recent full fiscal year despite recent quarterly positive net income of $1,955,328.00. The timing coincides with depressed valuations, but without clarity on the economic substance of the zero-valuation transfer, this filing warrants examination of the underlying grant documents or equity plan mechanics to determine if it signals management's conviction or is a routine compensation/structural event.

Lutnick (CEO) purchases 900,000 shares of CEPF in first acquisition at this private company vehicle.

Brandon Lutnick, the Chairman and CEO, acquired 900,000 shares on 2025-10-06, representing his first purchase in this security and bringing his holdings from 0 to 900,000 shares. The transaction was recorded at $0.00 total value, indicating a private placement or non-cash equity grant rather than a disclosable open-market purchase. While his cross-ticker track record shows 8 prior buys across other securities, this marks a new position in Cantor Equity Partners IV, Inc. The current price of $10.35 places the position at realistic market value despite the zero transaction price notation typical of non-monetary exchanges.

Lutnick (CEO) acquires 580,000 shares of CAEP at no cost; company reports net loss of $-63.5K

Brandon Lutnick, the company's Chairman and CEO, acquired 580,000 shares in Cantor Equity Partners III, Inc. on 2025-10-06 at no stated price (total value: $0.00), building an initial position in the company. The zero-cost nature of this transaction suggests this may be a compensation grant, equity award, or other non-cash instrument rather than an open-market purchase driven by discretionary investment conviction. Notably, the company reported a net loss of $-63.5K and the current stock price of $10.41 sits 4.9% below the 52-week high, placing the shares in a moderately depressed portion of their annual range. The insider's cross-ticker history shows 8 prior buys across all holdings, indicating a general propensity to accumulate positions, though this particular transaction's mechanics (zero-cost acquisition by the seated CEO) and the company's negative net income warrant closer examination of the economic context and vesting terms.

Lutnick (Chairman/CEO) buys 580,000 shares of CEPT at $0.00 valuation on 2025-10-06

Chairman and CEO Brandon Lutnick purchased 580,000 shares of Cantor Equity Partners II, Inc. on 2025-10-06 with no reported transaction value ($0.00), which raises questions about the economic substance and pricing mechanism of this acquisition. The transaction establishes a new position for Lutnick (0 shares pre-transaction), and while his cross-ticker track record shows 8 prior open-market buys, the absence of a disclosed price makes it impossible to assess whether this represents a material investment decision or a structural/administrative action. Current market price is $10.69, but this cannot be directly compared to a transaction priced at n/a. The filing requires examination to determine whether this is a bona fide market purchase, a private award, or a reporting artifact requiring clarification.